Secura Bio Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Secura Bio

Access the complete profile.

Secura Bio Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	1995 Village Center Cir Ste 128 Las Vegas, NV 89134

Note: Revenues for privately held companies are statistical evaluations.


Secura Bio's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Secura Bio's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Secura Bio is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Secura Bio Annual Revenue and Growth Rate

Secura Bio	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Secura Bio's revenues are gauged from an analysis of company filings.

Secura Bio's Income Statement (based on Industry Averages)

Secura Bio P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Secura Bio has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
April 1, 2019	2	56%	$90 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Secura Bio is developing and marketing. Secura Bio doesn't have any recent trademark applications, indicating Secura Bio is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SECURA BIO Pharmaceutical preparations for use in oncology, namely, for use in the treatment of myeloma, leukemia, glioma and lymphoma expressly excluding topical skin care preparations, namely, skin protectants, cleansers, moisturizers and antifungals	01/21/2020
COPIKTRA pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders	05/18/2016

See all trademarks and details in the Full Report.

Market Share of Secura Bio's Largest Competitors

A competitive analysis shows these companies are in the same general field as Secura Bio, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Secura Bio. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NECTARTEK	Las Vegas, NV	100
CNS SCRIPS	Las Vegas, NV	70
SECURA BIO	Las Vegas, NV	49
DRVITA INC. DBA EVA NUTRA	Las Vegas, NV	48
FORTE BIO-PHARMA	Las Vegas, NV	46
CANNVITAL NV	Las Vegas, NV	13

Future Competition: Secura Bio's Fastest Growing Competitors

These companies are in the same general field as Secura Bio and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)